On September 14, the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), in collaboration with the National Cancer Institute (NCI), published a series of RFAs (Requests for Applications) that are intended to stimulate multi-disciplinary research on developmental issues for individuals and families affected by differences or disorders of sex development (DSD), sometimes referred to as intersex conditions or by specific diagnostic terms (e.g., congenital adrenal hyperplasia).
The NICHD reached out to the Endocrine Society to ensure that members were aware of the RFAs, given the Society’s thoughtful comments to NICHD’s Request for Information (RFI) on the impacts of disorders of sex development (DSD) on child development for affected individuals and their families. The RFAs are informed by the RFI responses and a recent NICHD workshop on growing up with DSD.
Take Action: We encourage members to examine the RFAs at the following links:
RFA-HD-16-023: R21
RFA-HD-16-022: R03
RFA-HD-16-021: R01
The RFAs provide examples of the types of research topics that would be of interest to NICHD, but these are not intended to exclude applications for scientifically strong research projects in other topics; potential applicants are encouraged to discuss possible projects with the Institute staff identified in the RFAs.
NIH Makes $46M Commitment to Study Human Placenta
As reported previously in Endocrine Insider, the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) recently announced an initiative called the Human Placenta Project (HPP). The project was developed with the goal of studying the “structure and function of the placenta in real time.” Specific objectives include:
- Real time assessment and monitoring in normal and abnormal pregnancies;
- Biomarkers for adverse outcomes; and
- Interventions to prevent abnormal development.
On Monday, September 28, the NIH announced 19 awards totaling $46 million in fiscal year 2015. The awards “will support development of safe, noninvasive methods to monitor the placenta in real time, throughout all stages of pregnancy.”
Loading ...